Literature DB >> 12541195

Rickets in childhood.

Zulf Mughal1.   

Abstract

Bone accretion is a two-stage process, with the osteoblasts laying down osteoid, which is then mineralized. Mineralization of osteoid requires vitamin D to be available in its active form (1,25(OH) 2 D); in addition, mineralization also requires normal levels of serum calcium, phosphorus, and alkaline phosphate. Deficiencies of any of these will result in defective mineralization of bone, in which the mineral-osteoid ratio is reduced (a qualitative abnormality). In the juvenile skeleton deficiencies particularly affect enchondral ossification at the growth plates, giving the characteristic clinical and radiological features of rickets. The bone may be soft, leading to deformity. In this article the causes of rickets in childhood are reviewed, together with the clinical and radiological features and strategies for prevention and treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12541195     DOI: 10.1055/s-2002-36715

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  4 in total

1.  Is nutritional rickets returning?

Authors:  J Allgrove
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

Review 2.  Hypophosphatemic rickets: etiology, clinical features and treatment.

Authors:  Vito Pavone; Gianluca Testa; Salvatore Gioitta Iachino; Francesco Roberto Evola; Sergio Avondo; Giuseppe Sessa
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-06-24

3.  Enamel and dentin mineralization in familial hypophosphatemic rickets: a micro-CT study.

Authors:  T R Ribeiro; F W G Costa; E C S Soares; J R Williams; C S R Fonteles
Journal:  Dentomaxillofac Radiol       Date:  2015-02-04       Impact factor: 2.419

4.  Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005.

Authors:  Signe Sparre Beck-Nielsen; Tina Kold Jensen; Jeppe Gram; Kim Brixen; Bendt Brock-Jacobsen
Journal:  Eur J Pediatr       Date:  2008-11-05       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.